Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer.

Efforts to identify a potent, reversible, nonsteroidal CYP17A1 lyase inhibitor with good selectivity over CYP17A1 hydroxylase and CYPs 11B1 and 21A2 for the treatment of castration-resistant prostate cancer (CRPC) culminated in the discovery of BMS-351 (compound 18), a pyridyl biaryl benzimidazole with an excellent in vivo profile.

Biological evaluation of BMS-351 at a dose of 1. 5 mg in castrated cynomolgus monkeys revealed a remarkable reduction in testosterone levels with minimal glucocorticoid and mineralcorticoid perturbation. Based on a favorable profile, BMS-351 was selected as a candidate for further preclinical evaluation.

ACS medicinal chemistry letters. 2015 Dec 02*** epublish ***

Audris Huang, Lata Jayaraman, Aberra Fura, Gregory D Vite, George L Trainor, Marco M Gottardis, Thomas E Spires, Vanessa M Spires, Cheryl A Rizzo, Mary T Obermeier, Paul A Elzinga, Gordon Todderud, Yi Fan, John A Newitt, Sophie M Beyer, Yongxin Zhu, Bethanne M Warrack, Angela K Goodenough, Andrew J Tebben, Arthur M Doweyko, David L Gold, Aaron Balog

Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States. , Bristol-Myers Squibb Research and Development , Princeton, New Jersey 08543-4000, United States.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe